Role of Leucine in the Regulation of Human Myofibrillar Protein Synthesis at Rest and Following Resistance Exercise
1 other identifier
interventional
24
1 country
1
Brief Summary
Muscle mass is normally maintained through the regulated balance between the processes of protein synthesis (i.e. making new muscle proteins) and protein breakdown (breaking down old muscle proteins). Proteins are composed of amino acids and we know that amino acids increase muscle protein synthesis. However, not all amino acids are the same. Essential amino acids are ones that must be consumed through food, while non-essential amino acids can be made by our body. Interestingly, the essential amino acids are all that are required to increase the rate of muscle protein synthesis. In addition, the essential amino acid leucine appears to be particularly important in regulating protein synthesis. However, how leucine is able to increase protein synthesis is not entirely understood. Previously, it has been shown that 20-25 g of high-quality protein, such as that found in milk, appears to be the amount of protein that maximizes the rate of muscle protein synthesis after performing a bout of resistance exercise. Thus, the aim is to measure the synthesis of new muscle proteins after ingesting the following:
- 1.25g whey protein
- 2.6.25g whey protein supplemented with leucine
- 3.6.25g whey protein supplemented with essential amino acids but no leucine
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 12, 2011
CompletedFirst Posted
Study publicly available on registry
December 14, 2011
CompletedFebruary 24, 2020
February 1, 2020
2 months
December 12, 2011
February 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle protein synthesis
Muscle protein synthesis will be expressed as fractional synthetic rate (FSR) by dividing the increment in enrichment in the product, i.e. protein-bound C13phe, by the enrichment of the precursor (= intracellular availability).
5 hours postprandial
Secondary Outcomes (1)
Signaling molecule phosphorylation status
1, 3, and 5 hours
Study Arms (3)
25 g protein
EXPERIMENTAL25 g whey protein
6.25 g protein supplemented with leucine
EXPERIMENTAL6.25 g protein supplemented with leucine
6.25 g whey protein with EAA
EXPERIMENTAL6.25 g protein supplemented with a mixture of essential amino acids devoid of leucine
Interventions
6.25 g whey protein supplemented with free form leucine
6.25 g whey protein supplemented with essential amino acids devoid of leucine
Eligibility Criteria
You may qualify if:
- male
- years of age
- non-smoker/ non-tobacco product user
You may not qualify if:
- heart disease
- vascular disease
- rheumatoid arthritis
- diabetes
- poor lung function
- uncontrolled blood pressure
- dizziness
- thyroid problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McMaster Universitylead
- University of California, Daviscollaborator
- Canadian Institutes of Health Research (CIHR)collaborator
- Natural Sciences and Engineering Research Council, Canadacollaborator
Study Sites (1)
Exercise Metabolism Research Laboratory, McMaster Univeristy
Hamilton, Ontario, L8S 4K1, Canada
Related Publications (1)
Churchward-Venne TA, Burd NA, Mitchell CJ, West DW, Philp A, Marcotte GR, Baker SK, Baar K, Phillips SM. Supplementation of a suboptimal protein dose with leucine or essential amino acids: effects on myofibrillar protein synthesis at rest and following resistance exercise in men. J Physiol. 2012 Jun 1;590(11):2751-65. doi: 10.1113/jphysiol.2012.228833. Epub 2012 Mar 25.
PMID: 22451437DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stuart M Phillips, PhD
McMaster University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 12, 2011
First Posted
December 14, 2011
Study Start
June 1, 2010
Primary Completion
August 1, 2010
Study Completion
September 1, 2010
Last Updated
February 24, 2020
Record last verified: 2020-02